#Genomic Research Laboratory in India

[janetushar1]

Cancer Profiling Market to Hit $19.28 Billion by 2032

The global Cancer Profiling Market was valued at USD 9.4 Billion in 2024 and it is estimated to garner USD 19.28 Billion by 2032 with a registered CAGR of 10.8% during the forecast period 2024 to 2032.

The report throws light on the competitive scenario of the global Cancer Profiling Market to know the competition at global levels. Market experts also provided the outline of each leading player of the global Cancer Profiling Market for the market, considering the key aspects such as the areas of operation, production, and product portfolio. In addition, the companies in the report are studied based on vital factors such as company size, market share, market growth, revenue, production volume, and profit.

The global Cancer Profiling Market is fragmented with various key players. Some of the key players identified across the value chain of the global Cancer Profiling Market include Illumina Inc. (U.S.), QIAGEN (Germany), NeoGenomics Laboratories Inc. (U.S.), HTG Molecular Diagnostics Inc. (U.S.), Genomic Health Inc. (U.S.), Caris Life Sciences (U.S.), Helomics Corporation (U.S.), NanoString Technologies Inc. (U.S.), Sysmex Corporation (Japan), Ribomed Biotechnologies, Inc. (U.S.) etc. Considering the increasing demand from global markets various new entries are expected in the Cancer Profiling Market at regional as well as global levels.

Download Cancer Profiling Market Sample Report PDF: https://www.vantagemarketresearch.com/cancer-profiling-market-2101/request-sample

Top Competitors:

Illumina Inc. (U.S.), QIAGEN (Germany), NeoGenomics Laboratories Inc. (U.S.), HTG Molecular Diagnostics Inc. (U.S.), Genomic Health Inc. (U.S.), Caris Life Sciences (U.S.), Helomics Corporation (U.S.), NanoString Technologies Inc. (U.S.), Sysmex Corporation (Japan), Ribomed Biotechnologies, Inc. (U.S.)

Understanding the Industry's Growth, has released an Updated report on the Cancer Profiling Market. The report is mixed with crucial market insights that will support the clients to make the right business decisions. This research will help new players in the global Cancer Profiling Market to sort out and study market needs, market size, and competition. The report provides information on the supply and market situation, the competitive situation and the challenges to the market growth, the market opportunities, and the threats faced by the major players.

Regional Analysis

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/cancer-profiling-market-2101/0

Full Analysis Of The Cancer Profiling Market:

Key findings and recommendations point to vital progressive industry trends in the global Cancer Profiling Market, empowering players to improve effective long-term policies.

The report makes a full analysis of the factors driving the development of the market.

Analyzing the market opportunities for stakeholders by categorizing the high-growth divisions of the market.

Questions answered in the report

-Who are the top five players in the global Cancer Profiling Market?

-How will the global Cancer Profiling Market change in the next five years?

-Which product and application will take the lion's share of the global Cancer Profiling Market?

-What are the drivers and restraints of the global Cancer Profiling Market?

-Which regional market will show the highest growth?

-What will be the CAGR and size of the global Cancer Profiling Market during the forecast period?

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/cancer-profiling-market-2101

Reasons to Purchase this Cancer Profiling Market Report:

-Analysis of the market outlook on current trends and SWOT analysis.

-The geographic and country level is designed to integrate the supply and demand organizations that drive industry growth.

-Cancer Profiling Industry dynamics along with market growth opportunities in the coming years.

-Cancer Profiling Market value (million USD) and volume (million units) data for each segment and sub-segment.

1 year consulting for analysts along with development data support in Excel. Competitive landscape including market share of major players along with various projects and strategies adopted by players in the last five years.

Market segmentation analysis including qualitative and quantitative analysis including the impact on financial and non-economic aspects.

Complete company profiles that include performance presentations, key financial overviews, current developments, SWOT analyzes and strategies used by major Cancer Profiling Market players.

Check Out More Reports

Global Single-Use Bioprocessing Market:  Report Forecast by 2032

Global Medical Device Security Market: Report Forecast by 2032

Global Fitness Tracker Market: Report Forecast by 2032

Global Alternative Lending Platform Market: Report Forecast by 2032

Global Animal Feed Additives Market: Report Forecast by 2032

[shubhampawrainfinium]

Unlocking Breakthroughs with Cutting-Edge Scientific Instrumentation

The global analytical and scientific instrumentation market is anticipated to experience steady growth over the coming years. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of over 5% from 2022 to 2028. The market generated around USD 42 billion in revenue in 2022 and is expected to reach approximately USD 60 billion by 2028.

What is Analytical and Scientific Instrumentation?

Analytical and scientific instrumentation encompasses a wide array of devices and systems used to analyze, measure, and study materials at various levels, from chemical and biological analysis to physical measurements. These instruments are widely applied in fields such as healthcare, environmental science, industrial manufacturing, pharmaceuticals, and academic research. The market includes equipment such as spectrometers, chromatographs, microscopes, and other laboratory tools designed to deliver high-precision data for scientific and analytical purposes.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/42524

Market Dynamics and Growth Drivers

Several key factors are driving the expansion of the global analytical and scientific instrumentation market:

Technological Advancements: Continuous advancements in technology, such as the development of AI-driven analytics, high-resolution imaging, and automated laboratory processes, are enhancing the capabilities of analytical instruments, enabling more accurate and efficient analyses across applications.

Growth in Life Sciences and Pharmaceutical Research: The demand for precise and reliable analytical instruments is increasing within the life sciences and pharmaceutical sectors. As research accelerates in areas such as drug discovery, genomics, and personalized medicine, there is a strong need for advanced instrumentation.

Rising Environmental and Regulatory Concerns: Environmental monitoring has become critical due to growing regulatory requirements and the need for pollution control. Analytical instrumentation plays a vital role in monitoring air, water, and soil quality, making it essential for government agencies and private organizations alike.

Expansion in Emerging Markets: As industrialization and research activities increase in emerging markets, there is greater demand for scientific instrumentation. Countries in Asia-Pacific and Latin America are rapidly adopting advanced analytical tools, contributing to the market’s global growth.

Growing Adoption in Food and Beverage and Chemicals Sectors: The need for quality control and regulatory compliance in food safety and chemical manufacturing is driving the adoption of analytical instruments in these industries. These tools help in ensuring product quality, detecting contaminants, and meeting safety standards.

Regional Analysis

North America: North America holds a substantial share of the global analytical and scientific instrumentation market, supported by advanced research facilities, high R&D investment, and strong presence of leading companies. The U.S., in particular, is a major market due to significant investments in healthcare and life sciences research.

Europe: Europe is another prominent market, with strong demand across the pharmaceutical, environmental, and food safety sectors. Countries like Germany, France, and the U.K. lead in adopting cutting-edge scientific instrumentation for various applications.

Asia-Pacific: The Asia-Pacific region is expected to experience rapid growth, driven by industrialization, healthcare expansion, and research investments in countries like China, Japan, and India. The increasing presence of pharmaceutical and biotechnology companies in the region is further fueling demand for analytical instruments.

Latin America, Middle East & Africa: These regions are seeing gradual growth, with rising investments in healthcare infrastructure, environmental monitoring, and scientific research. The adoption of advanced instrumentation is increasing as organizations and institutions aim to improve research capabilities and comply with international standards.

Competitive Landscape

The global analytical and scientific instrumentation market is competitive, with several key players focusing on technological innovations, product expansions, and strategic partnerships. Major companies include:

Agilent Technologies: Agilent provides a broad range of analytical instruments, particularly in chromatography, spectrometry, and molecular analysis. The company’s innovations are widely used in life sciences, diagnostics, and applied chemical markets.

Thermo Fisher Scientific: Known for its diversified product portfolio, Thermo Fisher offers advanced laboratory instruments, consumables, and software. It has a significant market presence in life sciences, environmental monitoring, and industrial applications.

PerkinElmer: PerkinElmer specializes in analytical solutions for diagnostics, environmental, and food quality testing. The company’s products are widely used across healthcare, food, and environmental sectors for precise analysis and compliance.

Shimadzu Corporation: With a strong reputation for quality, Shimadzu provides advanced instruments in chromatography, spectroscopy, and materials testing. The company serves clients in the pharmaceutical, environmental, and industrial fields.

Waters Corporation: Waters is well-known for its innovative chromatography and mass spectrometry solutions, catering to the life sciences, food and beverage, and environmental sectors.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-analytical-and-scientific-instrumentation-market

Challenges and Opportunities

The analytical and scientific instrumentation market faces challenges, including high equipment costs, complex maintenance requirements, and the need for highly skilled personnel to operate advanced systems. Additionally, regulatory hurdles and budget constraints in certain regions may limit the adoption of high-end instruments.

However, the market presents ample opportunities, especially in emerging sectors such as nanotechnology, biotechnology, and precision medicine. The integration of artificial intelligence and machine learning in data analysis and interpretation further enhances the functionality of analytical instruments, making them invaluable for complex research and industrial applications.

Conclusion

The global analytical and scientific instrumentation market is set for steady growth, increasing from USD 42 billion in 2022 to approximately USD 60 billion by 2028 at a CAGR of over 5%. As advancements in technology continue to transform research, diagnostics, and quality control processes, the demand for sophisticated analytical tools will remain strong across various sectors. The market’s future lies in continued innovation and the expansion of applications, making scientific instrumentation a crucial component in scientific progress and industrial advancements worldwide.

Discover More of Our Reports

Surgical Navigation Software Market

[trendingrepots]

Molecular Diagnostics Market - Forecast, 2024 - 2030

Molecular Diagnostics Market Overview

The Molecular Diagnostics Market Size is forecast to reach $ 3240.4 Million by 2030, at a CAGR of 8.60% during forecast period 2024-2030. Molecular diagnostics can be demarcated as a group of techniques proficient in identifying specific genetic disparities in patients by using diverse technologies such as polymerase chain reaction, single nucleotide polymorphisms, electrophoresis, isothermal nucleic acid amplification technology, mass spectrometry to scrutinize biomarkers in the genome. Molecular diagnostics allows doctors to select an unsurpassed form of therapy by supporting the detection of maladies and possible risks. Moreover, it helps medical professionals to chart individualized or customer-specific plans. Therefore, accurate prescription and treatment duration help patients circumvent lengthy recapitulations of pointless drugs being used on patients recurrently with hostile effects. Besides cancer monitoring, molecular diagnostic can be used to manage infections like methicillin-resistant staphylococcus. Nevertheless, rising incidences of infections and cancer, augmenting health attentiveness among people, hiking demand for personalized medicines, and enlarging research and developmental activities are the factors set to drive the growth of the Molecular Diagnostics Industry for the period 2024-2030.

 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞

Report Coverage

The report: “Molecular Diagnostics Market Forecast (2024-2030)” by Industry ARC covers an in-depth analysis of the following segments of the Molecular Diagnostics Market.

By Product: Reagents, Instrument, and other devices.

By Application: Leukocyte Antigen Typing, Oncology, Blood screening, Transferrable ailments, and Others.

By Technology: TMA, In Situ Hybridization, PCR, DNA sequencing, INAAT, and Others.

By End User: Hospitals, Laboratories, CROs, and Other medical facilities.

By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

Geographically, North America’s Molecular Diagnostics Market accounted for the highest revenue share in 2021. The growth is owing to full-fledged healthcare infrastructure, the presence of top-notch pharmacy and biopharmaceutical companies, and the high disposable income of people. Furthermore, Asia-Pacific is poised to offer lucrative growth opportunities over the forecast period owing to rising disposable incomes and the higher class of the geriatric population, among many other reasons.

Intensifying cancer cases are said to be the preeminent driver driving the growth of the Molecular Diagnostics Market. The exorbitant cost of the associated treatments and instruments is said to reduce the market growth.

Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Molecular Diagnostics Market report.

[health-views-updates]

Untapped Potential: The Rise of Genomic Services in Developing Markets

The global Genomics Services Market is experiencing significant growth, with increasing demand for genomic testing, sequencing, and data analysis. According to a comprehensive report published by SNS Insider, the market is poised for exponential growth in the coming years, driven by advancements in next-generation sequencing (NGS) technologies, increasing applications in healthcare, and growing emphasis on precision medicine.

Market Overview

The Genomic Services Market Revenue has been on an upward trajectory due to factors such as the rise of personalized medicine, growing prevalence of genetic disorders, and advancements in genomic technologies. Genomics services encompass a wide range of services including DNA sequencing, gene expression analysis, bioinformatics, and genotyping, which are vital for disease diagnosis, drug development, and research. These services have paved the way for a deeper understanding of genetic makeup, allowing for the development of customized treatments and therapies.

Key Drivers of Market Growth

Technological Advancements: With the advent of technologies like NGS and CRISPR, the genomics industry has seen a revolutionary shift. These technologies have made genetic testing more accurate, affordable, and accessible, leading to an increased adoption rate. Furthermore, advancements in bioinformatics have allowed for faster and more precise data analysis, which is crucial in interpreting genomic data.

Rise in Personalized Medicine: The trend towards personalized or precision medicine has been a significant contributor to the growth of the genomics services market. Physicians are increasingly relying on genetic information to tailor treatment plans based on an individual's genetic profile. This approach has proven to be more effective, especially in the treatment of cancer, where therapies are customized to target specific genetic mutations.

Increased Research and Development (R&D) Activities: Growing investments in R&D by pharmaceutical companies and research institutions have significantly boosted the demand for genomic services. The integration of genomics in drug discovery and development has accelerated the process of identifying potential drug candidates, leading to faster development of new therapies.

Government Support and Initiatives: Several governments around the world are investing in genomics research, with initiatives aimed at understanding the genetic basis of diseases and developing advanced diagnostic and therapeutic solutions. These initiatives have further propelled the growth of the genomics services market.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/2873 

Market Segmentation

The genomics services market is segmented based on service type, application, and end-user. Major service types include DNA sequencing, gene expression analysis, bioinformatics, and others. Applications range from diagnostics to drug discovery, agriculture, and personalized medicine. Key end-users include pharmaceutical companies, research institutions, hospitals, and academic laboratories.

Regional Insights

The report highlights that North America dominates the genomics services market, primarily due to the presence of major players, advanced healthcare infrastructure, and increased funding for genomic research. However, the Asia-Pacific region is expected to witness the highest growth rate, driven by rising healthcare expenditures, growing awareness about genomics, and the establishment of new genomics facilities. Countries like China, India, and Japan are investing heavily in genomic research, further boosting the market in this region.

Competitive Landscape

The genomics services market is highly competitive, with key players focusing on strategic collaborations, mergers, and acquisitions to strengthen their market position. Companies are also investing in R&D to introduce innovative services and technologies that can enhance data accuracy and reduce turnaround time. Major companies operating in this sector include Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Eurofins Scientific, and PerkinElmer Inc.

Future Outlook

The future of the genomics services market looks promising, with continuous advancements in technology and increasing adoption of precision medicine. The integration of artificial intelligence (AI) and machine learning (ML) in genomic data analysis is expected to further enhance the capabilities of genomic services, leading to better diagnostic and therapeutic outcomes. Furthermore, the expansion of genomics in agriculture and non-invasive prenatal testing (NIPT) represents new growth opportunities for the market.

As the demand for personalized medicine continues to grow, the need for accurate and reliable genomic services will become more pronounced, driving the market towards unprecedented growth. The report from SNS Insider provides in-depth insights into market trends, growth drivers, challenges, and opportunities, offering a comprehensive analysis of the global genomics services market.

About Us

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Other Trending Reports

Healthcare Biometrics Market Growth

Diabetic Ulcer Treatment Market Growth

Venous Thromboembolism Treatment Market Growth

Cell Signaling Market Growth

[trendingreportz]

Single-cell Genome Sequencing Market - Forecast(2024 - 2030)

Single-cell Genome Sequencing Market Overview 

The Single-cell Genome Sequencing size is estimated to reach $9 billion by 2030, growing at a CAGR of 16.2% during the forecast period 2023-2030. Single-cell genome sequencing is one of the major areas of research for finding a cure for chronic ailments such as cancer. The rising cases of cancer worldwide would drive the Single-cell Genome Sequencing Market during the forecast period. According to Cancer.org, the global burden of new cancer cases would grow to 27.5 million by 2040. This would certainly boost the demand for Single-cell Genome Sequencing Market to find a cure for such chronic diseases.

Rapid development in sequencing technologies is also expected to drive the growth of this market during the forecast period. Polymerase chain reaction (PCR) and next-generation sequencing are emerging as the preferred technologies for various applications, especially for single-cell genomic sequencing. In January 2022, a group of medical Scientists at Stanford and their collaborators developed a new ultra-fast genome sequencing approach that offered a diagnostic rate of about 12% higher than the average rate for diagnosing mystery illnesses.

Request Sample

Single-cell Genome Sequencing Market - Report Coverage:

The “Single-cell Genome Sequencing Market Report- Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Single-cell Genome Sequencing Market.AttributeSegment

By Product Type

Consumables

Reagents

By Technique

Flow Cytometry

Next-generation Sequencing

Polymerase Chain Reaction

Microscopy

Mass Spectrometry

Others

By Application

Cancer

Immunology

Microbiology

Others

By End-User

Academic and Research Laboratories

Hospitals and Diagnostic Centers

Biotechnology and Pharmaceutical Companies

Cell Banks and IVF Centers

By Geography

North America (the U.S., Canada and Mexico)

Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific),

South America (Brazil, Argentina, Chile, Colombia and the Rest of South America)

The Rest of the World (the Middle East and Africa).

COVID-19 / Ukraine Crisis - Impact Analysis: 

The COVID-19 pandemic had a positive impact on the Single-cell Genome Sequencing Market. The studies on single-cell genome sequencing offered critical insights into coronavirus infection and allowed medical experts better understand the nature of the infection. On performing single-cell sequencing, most cell types in patients with COVID-19 showed a significant interferon-α response along with an overall acute inflammatory response.

 Russia’s invasion of Ukraine has made a significant impact on the Single-cell Genome Sequencing market. It has not only affected the lives and work of genomic researchers in these countries but has also influenced the relationships with colleagues in the U.S. and elsewhere.

The sanctions against Russia are most likely to bring experimental genomics research in the country to a halt. Ukraine had several genomics research projects going on before the war began. Now, with all the unrest, most researchers in Ukraine are fleeing the country and looking for positions in the west.

Inquiry Before Buying

Key Takeaways: 

Fastest Growth in the Asia-Pacific Region : Geographically, in the global Single-cell Genome Sequencing market share, Asia-Pacific is analyzed to grow with the highest CAGR of 17.2% during the forecast period 2023-2030. This growth is driven by the rising number of cancer cases in the region. According to the projections by the International Agency for Research on Cancer, there would be about 15.1 million new cases per year in Asia until 2040. The unprecedented rate of population aging is the key determinant of this development. Japan, the country with the oldest population in the world, also has the highest rate of cancer. This would drive growth in the Single-cell Genome Sequencing Market in the region during the forecast period.

Reagents Segment to Register the Fastest Growth : In the Single-cell Genome Sequencing analysis, the Reagents segment is estimated to grow with the highest CAGR of 17% during the forecast period. This is because the use of single-cell sequencing reagents allows the experts to process bulk samples with the input of as few as 100 cells. With the recent advancements in single-cell DNA sequencing techniques, bulk DNA sequencing can be done more efficiently and cost-effectively. Moreover, commercial reagents are now available for all the wet-lab steps of a scRNA-seq protocol as well as for preparing barcoded cDNA libraries. The increasing availability of reagents and their growing need in various single-cell genome sequencing processes are boosting its growth in the Single-cell Genome Sequencing Market during the forecast period.

Academic and Research Laboratories Segment is Leading the Market : According to the Single-Cell Genome Sequencing Market forecast, the academic and research laboratories segment held the largest market share of 38.6% in 2022. Single-cell genomics is emerging as one of the major areas in scientific research and development. The rising prevalence of chronic diseases demands new cures and treatment options, which is further boosting the growth of the academic and research laboratories segment. Moreover, understanding the genomics of individual cells opens up a new set of opportunities for the world of biotechnology.

Increased Funding for Vaccine Development and Production : Government agencies in various parts of the world have increased funding for the development and production of vaccines in response to the pandemic. This has led to increased use of single-cell analysis (SCA) tools for COVID-19 research. SCA helps in the assessment of the peripheral immune function of the disease and contributes to the study of the pathophysiology and treatment possibilities of the disease. Thus, the market is positively impacted by COVID-19.

Massive Demand in the field of Immunology, Oncology and Others : Single-cell technology is used in the molecular-level examination of processes and pathways of cellular heterogeneity along with its assessment. This rapidly developing technology has major applications in immunology, oncology and other major areas. Moreover, the development of advanced tools that help make proteomic and transcriptomic processes simpler is also driving the use of single-cell analysis methods, boosting the growth of the Single-cell Genome Sequencing Market.

High Cost of Instruments to Hinder Market Growth : While there is a significant demand for genome sequencing machines among the end-user industries, the instrument costs are significantly high. According to a report published in Bloomberg, Illumina’s new NovaSeq X series costs $985,000 for the base machine and $1.25 million for the advanced one. Such high cost of instruments are likely to hinder the growth of the Single-cell Genome Sequencing Market.

Schedule a Call

Key Market Players:

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Single-Cell Genome Sequencing Market.

The top 10 companies in this industry are listed below:

Standard BioTools Inc. (Maxpar®, Advanta™ Assays)

QIAGEN N.V. (QIAseq FX, REPLI-g)

Illumina, Inc. (NovaSeq, NextSeq)

F. Hoffmann-La Roche AG (AVENIO, MagNA Pure)

Thermo Fisher Scientific, Inc. (Invitrogen, Applied Biosystems)

Bio-Rad Laboratories, Inc. (SEQuoia, ddSEQ)

10X Genomics, Inc. (Chromium, Visium)

Becton, Dickinson and Company (BD Rhapsody™, BD AbSeq)

Oxford Nanopore Technologies Limited (MinION, GridION)

Beijing Genomics Institute Group (CardioGen, COLOTECT™)

 Buy Now

Scope of the Report:

Report MetricDetails

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

16.2%

Market Size in 2030

$9 billion

Segments Covered

Product Type, Technique, Application, End-user and Region

Geographies Covered

North America (the U.S., Canada and Mexico) Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and the Rest of the World (the Middle East and Africa).

Key Market Players

Standard BioTools Inc.

QIAGEN N.V.

Illumina, Inc.

F. Hoffmann-La Roche AG

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

10X Genomics, Inc.

Becton, Dickinson and Company

Oxford Nanopore Technologies Limited

Beijing Genomics Institute Group

Pacific Biosciences of California, Inc.

NuGEN Technologies, Inc.

Novogene Co. Ltd.

Takara Bio, Inc.

Danaher Corporation

[harshnews]

Primary Antibodies Market Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus

"Global Primary Antibodies Market – Industry Trends and Forecast to 2028

Global Primary Antibodies Market, By Type (Monoclonal Antibodies, Polyclonal Antibodies), Technology (Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Other Technologies), Source (Mouse, Rabbit, Goat, Other Sources), Research Area (Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology, Others), Application (Proteomics, Drug Development, Genomics), End User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Access Full 350 Pages PDF Report @

**Segments**

- Type: The primary antibodies market can be segmented based on type into monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are derived from a single parent cell, resulting in high specificity and consistency, while polyclonal antibodies are produced by multiple parent cells, offering a broader range of targets. - Application: The market can also be segmented according to application, including research applications, clinical diagnostics, and therapeutics. Research applications account for a significant portion of the market, driven by ongoing advancements in biotechnology and life sciences research. - End-user: End-user segmentation of the primary antibodies market includes academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations. Academic and research institutes are major consumers of primary antibodies for various research purposes.

**Market Players**

- Thermo Fisher Scientific Inc.: Known for its comprehensive range of primary antibodies, Thermo Fisher Scientific offers high-quality products for various research and diagnostic applications. - Abcam plc: Abcam is a prominent player in the primary antibodies market, offering a wide selection of validated antibodies for research purposes. - Merck KGaA: Merck KGaA provides primary antibodies through its life science division, catering to the needs of researchers and clinicians worldwide. - F. Hoffmann-La Roche Ltd: As a leading pharmaceutical company, Roche offers a diverse portfolio of primary antibodies for use in diagnostics and research. - Bio-Rad Laboratories, Inc.: Bio-Rad Laboratories is a key player in the market, offering primary antibodies that are widely used in research laboratories and clinical settings.

The global primary antibodies market is characterized by the presence of several established players who compete based on product quality, innovation, and strategic partnerships. These companies invest significantly in research and development to introduce new and improved primary antibodies, catering to the evolving needs of the healthcare and life sciences industries.

https://www.databridgemarketresearch.com/reports/global-primary-antibodies-marketThe primary antibodies market is a dynamic and rapidly evolving sector that plays a crucial role in various applications such as research, clinical diagnostics, and therapeutics. The segmentation of the market based on type into monoclonal antibodies and polyclonal antibodies highlights the diverse offerings in terms of specificity and target range. Monoclonal antibodies, derived from a single parent cell, provide high specificity and consistency, making them ideal for targeted applications. On the other hand, polyclonal antibodies offer a broader range of targets due to their production from multiple parent cells. This variety in antibody types caters to the specific needs of researchers and clinicians in different fields.

When considering the market segmentation based on application, it is evident that research applications hold a significant share of the primary antibodies market. The continuous advancements in biotechnology and life sciences research drive the demand for primary antibodies in research settings. Clinical diagnostics and therapeutics also play vital roles in driving the market, showcasing the versatility of primary antibodies across different sectors. The diverse applications of primary antibodies indicate the widespread adoption and utilization of these products in various industries.

End-user segmentation further enhances the understanding of the primary antibodies market by highlighting the different consumer groups. Academic and research institutes stand out as major end-users, utilizing primary antibodies for a wide range of research purposes. Pharmaceutical and biotechnology companies, as well as contract research organizations, also contribute significantly to the demand for primary antibodies. The diverse end-user base reflects the widespread use of primary antibodies across different sectors and underlines the importance of these products in advancing scientific research and diagnostics.

Market players such as Thermo Fisher Scientific Inc., Abcam plc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories, Inc. are key contributors to the global primary antibodies market. These companies are known for their extensive product offerings, quality assurance, and commitment to innovation. By investing in research and development, these market players continue to introduce new and improved primary antibodies that align with the evolving needs**Segments:** - Type: The primary antibodies market can be segmented into monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies offer high specificity and consistency, while polyclonal antibodies provide a broader range of targets. - Application: Segmentation based on application includes research, clinical diagnostics, and therapeutics. Research applications dominate the market driven by advancements in biotechnology. - End-user: End-user segmentation comprises academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations.

The global primary antibodies market, segmented by type, application, and end-user, is a dynamic sector with significant contributions from established players such as Thermo Fisher Scientific Inc., Abcam plc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories, Inc. These companies compete based on product quality, innovation, and strategic partnerships, driving growth and development in the market. The market's segmentation enables a deeper understanding of the diverse offerings of monoclonal and polyclonal antibodies, catering to the evolving needs of researchers and clinicians across various industries.

The application segment showcases the market's versatility, with research applications holding a substantial share due to ongoing advancements in biotechnology and life sciences research. Clinical diagnostics and therapeutics also play crucial roles, underlining the widespread adoption of primary antibodies in diverse sectors. Additionally, end-user segmentation sheds light on the varied consumer groups, with academic and research institutes emerging as significant users of primary antibodies for research purposes. Pharmaceutical

The Primary Antibodies Market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance.

Major Points Covered in TOC:

Primary Antibodies Market Overview: It incorporates six sections, research scope, significant makers covered, market fragments by type, Primary Antibodies Market portions by application, study goals, and years considered.

Primary Antibodies Market Landscape: Here, the opposition in the Worldwide Primary Antibodies Market is dissected, by value, income, deals, and piece of the pie by organization, market rate, cutthroat circumstances Landscape, and most recent patterns, consolidation, development, obtaining, and portions of the overall industry of top organizations.

Primary Antibodies Profiles of Manufacturers: Here, driving players of the worldwide Primary Antibodies Market are considered dependent on deals region, key items, net edge, income, cost, and creation.

Primary Antibodies Market Status and Outlook by Region: In this segment, the report examines about net edge, deals, income, creation, portion of the overall industry, CAGR, and market size by locale. Here, the worldwide Primary Antibodies Market is profoundly examined based on areas and nations like North America, Europe, China, India, Japan, and the MEA.

Primary Antibodies Application or End User: This segment of the exploration study shows how extraordinary end-client/application sections add to the worldwide Primary Antibodies Market.

Primary Antibodies Market Forecast: Production Side: In this piece of the report, the creators have zeroed in on creation and creation esteem conjecture, key makers gauge, and creation and creation esteem estimate by type.

Keyword: Research Findings and Conclusion: This is one of the last segments of the report where the discoveries of the investigators and the finish of the exploration study are given.

The Report Can Answer the Following Questions:

Who are the global key players of Primary Antibodies industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?

What are the types and applications of Primary Antibodies? What is the market share of each type and application?

What are the upstream raw materials and manufacturing equipment of Primary Antibodies? What is the manufacturing process of Primary Antibodies?

Economic impact on Primary Antibodies industry and development trend of Primary Antibodies industry.

What are the key factors driving the global Primary Antibodies industry?

What are the key market trends impacting the growth of the Primary Antibodies market?

What are the Primary Antibodies market challenges to market growth?

What are the Primary Antibodies market opportunities and threats faced by the vendors in the global Primary Antibodies market?

Browse Trending Reports:

6g Substrate Materials Market Cloud Application Programming Interface Api And Management Platforms And Middleware Market Abscisic Acid Aba Market Benign Mesonephroma Market Cancer Supportive Care Products Market Data Center Interconnect Market Potash Fertilizers Market Private Label Food And Beverage Market Relational Database Market Commercial Lighting Market Ethoxylates Market Eclinical Solutions Market Vaccines Market Spark Plug Market High Visibility Clothing Market Gas Turbine Services Market Dessert Mix Market Lipid Nutrition Market Barrier Films Flexible Electronics Market Nasal Polyposis Drugs Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[deshpandeisha]

Overview of Liquid Biopsy in Breast Cancer: Innovations and Applications

The global breast cancer liquid biopsy market size reached USD 5.14 Billion in 2022 and is expected to register a revenue CAGR of 22.7% during the forecast period, according to latest analysis by Emergen Research. Rising demand for minimally invasive approaches in oncology is driving revenue growth of the market. Liquid biopsy is a non-invasive method for identification of tumor markers, either as an alternative for patients whose tissue is unable to be biopsied, or to evaluate drug response. It is less costly than tumor tissue biopsy and offers an accurate understanding of genomic landscape of a tumor. Liquid biopsy is witnessing increased demand in diagnosis of solid and other tumors. In addition, one of the other key factors driving market revenue growth is expansion of research & development into the creation of breast cancer liquid biopsy solutions to address breast-related issues and conditions. Development of novel technologies is made possible by the increasing number of research activities carried out by an array of institutions around the world. Effectiveness of newer technologies makes it easier for them to enter the market.

The report digs into the key segments and sub-segments of the industry and offers a thorough study of the industry’s leading regional markets, competitive scenario, product and application segments, technology landscape, sales & distribution networks, and key industry statistics. Market insights included in the report have been compiled through extensive research, detailed market surveys, and expert interviews.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/1816

The leading market contenders listed in the report are: The Menarini Group, NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd., Myriad Genetics, Inc., QIAGEN, Biocept, Inc., Sysmex Corporation, Fluxion Biosciences, Inc., Epic Sciences, Inc., and Thermo Fisher Scientific Inc

The research study examines historic data from 2018 and 2020 to draw forecasts until 2030. The timeline makes the report an invaluable resource for readers, investors, and stakeholders looking for key insights in readily accessible documents with the information presented in the form of tables, charts, and graphs. To Visit Full Report & Table of Contents Breast Cancer Liquid Biopsy Market: https://www.emergenresearch.com/industry-report/breast-cancer-liquid-biopsy-market

Market Overview: The report bifurcates the Breast Cancer Liquid Biopsy market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment. Segments Covered in this report are:

Application Outlook (Revenue, USD Billion; 2019-2032)

Early Detection/Screening

Diagnosis

Others

Circulating Biomarker Outlook (Revenue, USD Billion; 2019-2032)

Circulating Tumor Cells

Extracellular Vesicles  

Others

Regional Outlook (Revenue, USD Billion; 2019–2032)

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Benelux

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Rest of APAC

Latin America

Brazil

Rest of LATAM

Middle East & Africa

Saudi Arabia

UAE

South Africa

Turkey

Rest of MEA

The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market. Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/1816

Regional Analysis Covers: North America (U.S., Canada) Europe (U.K., Italy, Germany, France, Rest of EU) Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key reasons to buy the Global Breast Cancer Liquid Biopsy Market report:

The latest report comprehensively studies the global Breast Cancer Liquid Biopsy market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.

The report offers an insightful analysis of the regional outlook of the market.

It offers a detailed account of the end-use applications of the products & services offered by this industry.

The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1816

[blueweave8]

India Food Safety Testing Market Industry Trends, Demand, Report 2023-2030

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated India Food Safety Testing Market size by value at USD 388.03 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects India Food Safety Testing Market size to expand at a CAGR of 7.82% reaching a value of USD 636.9 million by 2030. The Food Safety Testing Market in India is propelled by the growing consumer awareness about food safety and quality concerns and rapidly expanding population. The stringent regulatory framework enforced by the Food Safety and Standards Authority of India (FSSAI) is instrumental, in ensuring compliance with rigorous safety standards. The market encompasses diverse testing methodologies, including microbiological, chemical, and physical testing, with a notable trend toward rapid and automated technologies. The demand for food safety testing is particularly pronounced in urban areas but is poised to extend into rural regions as government initiatives promote awareness and infrastructure development. Moreover, the globalization of the food supply chain is creating a pressing need for comprehensive testing solutions, especially for imported products.

Sample Request: https://www.blueweaveconsulting.com/report/india-food-safety-testing-market/report-sample

Opportunity - Growing Interest in Personalized Nutrition

The growing interest in personalized nutrition presents a significant opportunity for the India Food Safety Testing Market. As consumers increasingly seek customized dietary solutions to manage weight and prevent disease, the demand for accurate and reliable food testing has surged. This trend highlights the need for rigorous testing of food products to ensure they meet safety standards and support personalized nutrition goals. With advancements in technologies such as genomics, proteomics, and metabolomics, coupled with a rising emphasis on health and wellness, the market for food safety testing in India is poised for robust growth. This expanding market is driven by the need to validate nutritional content and ensure the safety of personalized dietary recommendations, further underscoring the critical role of food safety testing in supporting the personalized nutrition sector.

South India Dominates India Food Safety Testing Market

South India's burgeoning food processing sector, coupled with heightened consumer awareness and stringent regulatory oversight, has catalyzed a surge in demand for comprehensive food testing services. Karnataka, Tamil Nadu, and Kerala have witnessed a proliferation of food-related enterprises, driving the need for robust quality assurance measures. The region's prominence is further cemented by the presence of leading food testing laboratories and research institutions, complemented by proactive state government initiatives to bolster food safety. As urbanization accelerates and consumer preferences evolve, the imperative for rigorous food testing to safeguard public health and ensure adherence to standards becomes increasingly paramount.

Impact of Escalating Geopolitical Tensions on India Food Safety Testing Market

India Food Safety Testing Market may face significant challenges from intensifying geopolitical tensions across the world. These tensions can disrupt global supply chains, leading to delays in the movement of food products and raw materials. Such disruptions can compromise the safety and quality of these items. Moreover, increased geopolitical risks may divert focus and resources away from food safety initiatives towards national security concerns. The diversion could hinder the development and implementation of advanced food testing technologies, ultimately affecting the market's growth and the ability to maintain high food safety standards.

Competitive Landscape

India Food Safety Testing Market is fragmented, with numerous players serving the market. The key players dominating India Food Safety Testing Market include SGS India Private Limited, TUV India Private Limited, Intertek India Private Limited, ALS Testing Services India Private Limited, BioMerieux India Private Limited, Qiagen India Private Limited, Bio-Rad Laboratories India Private Limited, Eurofins Analytical Services India Private Limited, Bureau Veritas Consumer Products Services Private Limited, and Thermo Fisher Scientific India Private Limited. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com

[tushar38]

Total Lab Automation Market: Driving Factors and Technological Advancements

Introduction to Total Lab Automation Market

The Total Lab Automation Market is experiencing robust growth as laboratories across industries look to improve efficiency, accuracy, and throughput. By automating the entire workflow—from sample preparation to analysis—lab automation systems help reduce human error, enhance reproducibility, and speed up research. As industries such as healthcare, pharmaceuticals, and biotechnology increasingly rely on automation to handle large volumes of testing, demand for total lab automation solutions continues to rise. Driven by advancements in robotics, artificial intelligence, and data analytics, this market is poised for significant expansion.

The TotaI Lab Automation Market is Valued USD 5.2 billion in 2024 and projected to reach USD 8.1 billion by 2030, growing at a CAGR of 6.5% During the Forecast period of 2024-2032..Total lab automation (TLA) systems integrate various laboratory functions into a seamless automated workflow. These systems have widespread applications in healthcare diagnostics, drug discovery, genomics, and chemical analysis. The market is witnessing significant technological advancements, including AI-powered automation, enhanced robotics, and sophisticated data management tools. As laboratories focus on reducing operational costs and improving accuracy, the adoption of TLA systems is expected to surge.

Access Full Report :https://www.marketdigits.com/checkout/3783?lic=s

Major Classifications are as follows:

By Type

Software

Equipment

By Application

Proteomics

Protein Engineering

Genomics

Drug Discovery

Clinical Diagnostics

Bio-analysis

Analytical Chemistry

By End User

Pharmaceutical Companies

Hospitals and Diagnostic Centers

Educational Institutions

Contract Research Organizations (CROs)

Research Institutes

Key Region/Countries are Classified as Follows:

◘ North America (United States, Canada,) ◘ Latin America (Brazil, Mexico, Argentina,) ◘ Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) ◘ Europe (UK,Germany,France,Italy,Spain,Russia,) ◘ The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South

Key Players of Total Lab Automation Market

Thermo Fisher Scientific Inc, Siemens Healthineers AG, Agilent Technologies, Inc., PerkinElmer, Inc, Beckman Coulter, Inc. (Danaher Corporation), Roche Diagnostics, Abbott Laboratories, Hamilton Company, Bio-Rad Laboratories, Inc., Hudson Robotics Inc and Others.

Market Drivers in Total Lab Automation Market

Several factors are driving the growth of the Total Lab Automation Market:

Increasing Laboratory Workload: The rise in diagnostic tests and research applications has put pressure on laboratories, encouraging the adoption of automation to increase throughput and efficiency.

Demand for Precision and Accuracy: Automation minimizes human errors and increases the reliability of results, which is critical in sectors like healthcare and pharmaceuticals.

Technological Advancements: The integration of AI, machine learning, and robotics has significantly improved the capabilities of lab automation, enabling smarter systems and faster processes.

Market Challenges in Total Lab Automation Market

While the Total Lab Automation Market has tremendous growth potential, it also faces several challenges:

High Initial Investment: The cost of implementing total lab automation solutions can be prohibitively high for small and mid-sized laboratories, limiting widespread adoption.

Complexity of Integration: Automating the entire workflow in a laboratory requires significant changes to infrastructure, which can lead to disruptions and require specialized training for staff.

Data Management Issues: As labs become fully automated, the amount of data generated also increases. Managing, analyzing, and ensuring data privacy remains a challenge.

Market Opportunities in Total Lab Automation Market

The Total Lab Automation Market presents numerous opportunities for growth:

Expanding Applications: Automation can be further applied in emerging fields such as genomics, personalized medicine, and drug discovery, where speed and accuracy are crucial.

Advancements in AI and Machine Learning: The integration of AI-driven algorithms offers the potential for predictive analytics, automated decision-making, and error detection, creating smarter automated systems.

Growth in Healthcare and Diagnostics: The rising need for rapid diagnostic tests, especially after the COVID-19 pandemic, has created a fertile ground for the expansion of automation in clinical labs.

Conclusion

The Total Lab Automation Market is set for significant growth as laboratories across the globe seek to enhance efficiency, reduce errors, and meet rising demand for high-throughput testing. While the market faces challenges, such as high implementation costs and data management issues, the ongoing advancements in AI, robotics, and software offer immense opportunities for future growth. As industries like healthcare, biotechnology, and pharmaceuticals continue to evolve, the role of total lab automation will be pivotal in shaping the future of laboratory operations.

[creativeera]

DNA and RNA Sample Preparation Market is Estimated to Witness High Growth Owing to Increasing Adoption

The DNA and RNA sample preparation market involves processes associated with isolation, extraction, purification and quantification of nucleic acids DNA and RNA from various sources like tissues, blood, sperm, cells etc. for downstream applications in genomics, molecular diagnostics, personalized medicine and others. The sample preparation is a critical and initial step before conducting various genomic tests including Next Generation Sequencing, polymerase chain reaction and other assays. Growing awareness and adoption of precision medicine and genetic/molecular testing is driving demand for efficient nucleic acid isolation and downstream analysis.

The Global DNA and RNA Sample Preparation Market is estimated to be valued at US$ 2262.46 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the DNA and RNA sample preparation are Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., DiaSorin S.p.A, F. Hoffmann-La Roche, Miroculus, Inc., Illumina, Inc., PerkinElmer, Inc., QIAGEN, Sigma Aldrich Corp., Tecan Group AG, and Thermo Fisher Scientific, Inc. Growing prominence of personalized medicine is creating opportunities for development of new sample preparation methods and kits which can extract nucleic acids from various types of samples. Rising incidence of chronic and infectious diseases worldwide is increasing diagnostic testing which will propel sample preparation market growth. Global expansion of key market players through acquisitions and partnerships with regional diagnostic labs and research institutes will further augment market revenues. Market Drivers Increasing funding for Genomic and genetic research from government bodies as well as private sector is one of the key factors driving the DNA and RNA Sample Preparation Market Size. Government initiatives aimed at large scale population screening and clinical testing for various genetic disorders, infectious diseases and cancers are also creating demand for high throughput nucleic acid preparation. Growing geriatric population and rising healthcare spending in developing nations also provides growth opportunities for market players in the forecast period.

PEST Analysis Political: Laws and regulations imposed by governments for research using DNA and RNA samples could impact the market. Changes in healthcare policies will also have effects. Economic: Factors like GDP growth, income levels, healthcare spending will drive demand. Rise in research activities and focus on precision medicine boost the market. Social: Growing awareness about personalized medicine and importance of genetic testing are important. Social trends also promote preventive healthcare and wellness. Technological: Advancements in fields like next generation sequencing, lab automation, bioinformatics are key for market growth. Miniaturization and portability of equipment expand applications. Developments in sample collection and storage methods improve efficiency. Geographical regions where the market in terms of value is concentrated include North America and Europe. North America accounts for the largest share in the global market due to presence of well-established healthcare industry and research institutes. Europe also captures notable share due to growing biotech sector and research funding. The Asia Pacific region is projected to be the fastest growing market during the forecast period. This is attributed to factors such as increasing healthcare expenditure, growing awareness, expanding biotech industry and rising government investments in research. Countries like China, India offer growth opportunities as they focus on healthcare infrastructure development.

Get more insights on DNA And RNA Sample Preparation Market

Also read related article on Surgical Robots Market

Discover the Report for More Insights, Tailored to Your Language

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

[saeedmohammedsblog]

Exploring Your Roots: Why DNA Testing is Essential for Family History Research

Family history research has fascinated millions worldwide. Discovering the stories of our ancestors, uncovering hidden heritage, and tracing family lines have become a passion for many. In recent years, technological advancements have made it possible to take genealogy research to the next level with DNA testing. For individuals in India, DNA testing services have become a vital tool in unravelling complex family histories. Understanding where you come from is not only about curiosity but can also have practical benefits, from health insights to legal cases involving lineage.

In this blog, we’ll explore how a DNA testing service in India can revolutionise your understanding of family history and why it has become an essential part of genealogical research.

What is DNA Testing?

DNA testing is a scientific method used to analyse your genetic material, or DNA, which holds all the information about your ancestry. By examining certain markers in your DNA, testing services can determine relationships between individuals, estimate ancestral origins, and even offer insights into inherited traits. These tests can reveal details about your ethnic background, connecting you to geographical regions or cultural groups that you may not have known you were linked to.

The Evolution of Genealogy: From Paper to DNA

Historically, genealogy was conducted using documents such as birth certificates, marriage records, and other historical documents. While these records can provide valuable information, they are often incomplete or unavailable, especially in countries like India, where historical records may not be well-preserved. This is where DNA testing services in India have stepped in to fill the gaps in family research.

DNA testing offers a precise and scientific method of uncovering family history, which complements traditional genealogy. It allows individuals to look beyond what is written in old records, providing concrete evidence of ancestry, ethnicity, and biological relationships.

How Does DNA Testing Work?

A DNA test involves the analysis of a sample of your genetic material, which is typically obtained via a cheek swab or saliva sample, in a laboratory setting. This sample is examined to identify specific genetic markers that can provide information about your ancestry. 

A variety of DNA testing options exist, such as:

- Y-DNA Testing: This test is specifically for men and traces the direct paternal line, providing information about the father’s ancestry.

- mtDNA Testing: This examination is utilised to explore maternal lineage and is available for both males and females.

- Autosomal DNA Testing: The most common form of testing, autosomal DNA tests analyse the entirety of your genome, giving a more comprehensive view of your ancestry from both maternal and paternal sides.

DNA testing services in India often offer these tests individually or as part of a package, making it accessible for anyone interested in tracing their roots.

Why Choose DNA Testing for Family History Research?

1. Connecting with Lost Relatives

One of the most compelling reasons to opt for a DNA testing service in India is the potential to connect with long-lost relatives. Many DNA databases allow you to match with others who have taken the test, making it possible to find previously unknown cousins, distant relatives, or even half-siblings. For individuals looking to build a more complete family tree, this can be invaluable.

2. Filling in Gaps in Family Records

For people in India, where official records may not always be well-documented or preserved, DNA testing can help fill the gaps. Whether your family records are missing, incomplete, or simply not available, DNA testing provides a way to confirm relationships and ancestral lines without relying solely on paper records.

3. Discovering Ethnic and Geographic Origins

One of the unique benefits of DNA testing is the ability to trace your roots back to specific geographic regions. Many DNA testing services can give you a breakdown of your ethnic heritage, sometimes linking you to regions or tribes you may not have known were part of your family’s history. This can be especially interesting in India, where cultural and ethnic diversity is vast.

4. Health Insights

Some DNA testing services in India also offer tests that provide insights into your health risks and inherited conditions. Understanding your genetic predispositions can be crucial for preventative healthcare and early detection of potential health problems. While family history research is primarily focused on lineage, the health insights gained from DNA testing can be a bonus.

5. Legal Purposes

DNA testing can also be used for legal reasons, such as proving lineage in inheritance disputes, custody cases, or other situations where establishing biological relationships is necessary. A DNA testing service in India can provide legally recognised results that can be used in court or for other official purposes.

The Process: What to Expect from DNA Testing Services in India

The process of undergoing a DNA test is simple and non-invasive. Most DNA testing services in India follow a standard process:

1. Ordering the Test Kit: You can order a DNA test kit online, which will be delivered to your home. These kits typically contain everything you need to collect a DNA sample.

2. Collecting the Sample: The most common method of collection is a cheek swab, but some services may require a saliva sample. Instructions for sample collection are straightforward to follow.

3. Sending the Sample Back: Once you have collected your sample, you will send it back to the testing service for analysis.

4. Receiving the Results: After a few weeks, your results will be available, often through a secure online portal. Your report will provide detailed information about your ancestry, ethnicity, and potential relative matches.

Choosing the Right DNA Testing Service in India

When choosing a DNA testing service in India, it’s important to consider several factors, including the accuracy of the test, the size of the database (for matching relatives), and whether the service offers additional features like health reports or legal certification. Be sure to research different options and choose a service that best fits your needs.

Conclusion: The Importance of DNA Testing in Genealogical Research

DNA testing has transformed the field of genealogy, offering individuals in India a powerful tool to explore their roots, fill in gaps in family history, and connect with lost relatives. Whether you’re looking to discover more about your ethnic heritage, understand your family’s history, or gain health insights, DNA testing is a vital resource. With the growing availability of DNA testing services in India, uncovering your family’s past has never been easier or more accessible.

Embark on your journey of self-discovery and unlock the mysteries of your ancestry with DNA testing services in India—it’s the key to exploring your roots like never before.

[businessindustry]

Media Dispensing Systems Market Report, Industry News 2024-2032

The Reports and Insights, a leading market research company, has recently releases report titled “Media Dispensing Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Media Dispensing Systems Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Media Dispensing Systems?

The media dispensing systems market is expected to grow at a CAGR of 5.2% during the forecast period of 2024 to 2032.

What are Media Dispensing Systems Market?

Media dispensing systems are automated machines designed to efficiently manage and distribute various types of media, including paper, film, or digital content, across different settings. Used in industries such as printing, manufacturing, and media production, these systems streamline operations by reducing manual handling and improving accuracy in media management. Features of media dispensing systems often include precise dispensing controls, automatic alignment, and integration with other equipment to ensure smooth and reliable operation. They enhance productivity, minimize waste, and maintain consistent quality in media-related processes.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/1911

What are the growth prospects and trends in the Media Dispensing Systems Market industry?

The media dispensing systems market growth is driven by various factors and trends. The media dispensing systems market is expanding as industries look for efficient ways to manage and distribute different types of media, such as paper, film, and digital content. This growth is driven by the increasing automation in sectors like printing, manufacturing, and media production, where these systems improve productivity, precision, and operational efficiency. Technological advancements, including enhanced dispensing controls and better integration with other equipment, are also contributing to market growth. Additionally, the demand for streamlined workflows and reduced manual handling is increasing the need for advanced media dispensing solutions, making them essential for optimizing media-related processes. Hence, all these factors contribute to media dispensing systems market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Product Type:

Manual Media Dispensers

Automated Media Dispensers

By Technology:

Gravimetric Dispensing

Volumetric Dispensing

Time Pressure Dispensing

By Application:

Drug Discovery and Development

Clinical Diagnostics

Bioprocessing

Cell Culture

Genomics and Proteomics

Other Applications

By End-Use:

Pharmaceutical and Biotechnology Companies

Research Institutes and Academic Centers

Contract Research Organizations (CROs)

Diagnostic Laboratories

Other End Users

Market Segmentation By Region:

North America:

United States

Canada

Europe:

Germany

The U.K.

France

Spain

Italy

Russia

Poland

BENELUX

NORDIC

Rest of Europe

Asia Pacific:

China

India

Japan

South Korea

Australia

New Zealand

ASEAN

Rest of Asia Pacific

Latin America:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East & Africa:

Saudi Arabia

United Arab Emirates

South Africa

Egypt

Israel

Rest of MEA.

Who are the key players operating in the industry?

The report covers the major market players including:

Thermo Fisher Scientific Inc.

PerkinElmer, Inc.

Eppendorf AG

Sartorius AG

Gilson, Inc.

Agilent Technologies, Inc.

Tecan Group Ltd.

Hamilton Company

Mettler-Toledo International Inc.

Bio-Rad Laboratories, Inc.

Corning Incorporated

BrandTech Scientific, Inc.

Labnet International, Inc.

Integra Biosciences AG

Biohit Oyj

Discover more: https://www.reportsandinsights.com/report/media-dispensing-systems-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: sales@reportsandinsights.com Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

[health-views-updates]

Technological Advancements: How They Are Transforming the Real-Time PCR (qPCR) Market

The global Real-Time PCR (qPCR) market Revenue, valued at USD 5.7 billion in 2023, is on a trajectory for significant growth, expected to reach USD 8.4 billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 5.1% during the forecast period from 2024 to 2031. The growth in this market is driven by the increasing demand for qPCR technology in various applications, including clinical diagnostics, research, and food safety.

Real-Time PCR, also known as quantitative Polymerase Chain Reaction (qPCR), is a revolutionary technique that allows for the amplification and quantification of DNA in real-time. This technology has become a cornerstone in molecular biology, enabling researchers and clinicians to detect and analyze genetic material with unprecedented accuracy and speed. The growing prevalence of infectious diseases and genetic disorders is fueling the demand for qPCR-based diagnostics, particularly in the wake of global health crises.

One of the primary factors contributing to the growth of the qPCR market is the rising adoption of personalized medicine. As healthcare moves towards tailored treatment strategies, qPCR plays a vital role in genetic profiling and biomarker discovery, helping to identify the most effective therapies for individual patients. Furthermore, advancements in qPCR technologies, such as the development of high-throughput systems and miniaturized devices, are enhancing the efficiency and accessibility of this powerful technique.

Market Trends and Innovations

Increased Investment in Research and Development: The growing emphasis on genomics and proteomics research is driving significant investments in R&D, particularly in academic and research institutions. This trend is expected to propel the development of novel qPCR assays and applications, further expanding the market.

Expansion of Applications: The applications of qPCR are broadening beyond clinical diagnostics. Industries such as agriculture, environmental monitoring, and food safety are increasingly utilizing qPCR technology to detect pathogens and genetically modified organisms (GMOs), creating new opportunities for market growth.

Emergence of Point-of-Care Testing: The shift towards point-of-care testing is gaining momentum, particularly in developing regions. The portability and ease of use of qPCR devices are making them increasingly popular for rapid diagnostics in remote areas, enhancing patient access to quality healthcare.

Technological Advancements: Continuous innovations in qPCR technologies, including digital PCR and advanced detection systems, are improving the sensitivity and specificity of assays. These advancements are attracting more users to adopt qPCR for various applications.

Get Free Sample Report@ https://www.snsinsider.com/sample-request/2573

Regional Insights

North America holds the largest share of the Real-Time PCR market, driven by the presence of key players, advanced healthcare infrastructure, and strong funding for research initiatives. The United States, in particular, is a leader in qPCR technology, with a robust market for clinical diagnostics and research applications.

The Asia-Pacific region is expected to witness the highest growth during the forecast period, fueled by increasing healthcare expenditures, growing awareness of advanced diagnostic techniques, and a rising number of research initiatives. Countries like China and India are investing significantly in biotechnology and molecular diagnostics, further propelling the adoption of qPCR technology.

Key Players in the Market

The Real-Time PCR market features several prominent players focused on product innovation, strategic collaborations, and acquisitions to enhance their market presence. Key companies in this market include Thermo Fisher Scientific, Roche, Bio-Rad Laboratories, Agilent Technologies, and Qiagen. These companies are continuously investing in research and development to deliver advanced qPCR solutions that meet the evolving needs of customers.

Conclusion

The global Real-Time PCR (qPCR) market is poised for substantial growth in the coming years, driven by the increasing demand for rapid and accurate diagnostic tools, advancements in technology, and the expansion of applications across various industries. As the need for efficient genetic analysis continues to rise, the qPCR market presents significant opportunities for innovation and growth for industry players.

[trendingreportz]

Clinical Oncology Next Generation Sequencing Market - Forecast(2024 - 2030)

Clinical Oncology Next Generation Sequencing Market Overview

Clinical Oncology Next Generation Sequencing Market size was valued at $1.4 billion in 2020 and projected to grow at a CAGR of 13.6% during the forecast period 2021-2026. Next-generation sequencing is a technique that helps to simultaneously perform multiple reactions from which it is possible to sequence DNA or RNA. Biological sciences have been revolutionized by massively parallel sequencing technologies i.e. next-generation sequencing (NGS). Targeted sequencing and re-sequencing provides advantages such as high throughput and lower cost per sample of the process thereby enhancing its application Companion Diagnostics. It is a method of assessing the nucleotide sequence in a DNA section and is used for oncology research and enables researchers to carry out a wide range of applications and study biological systems with their ultra-high throughput, scalability, and speed at a level never before possible. In addition, sequencing of the next generation helps in the evaluation of several genes in a single assay, thus reducing the need to order numerous tests to evaluate the underlying mutation thereby driving the Clinical Oncology Next Generation Sequencing Market. In tumour science, a high implementation rate in whole-genome sequencing (WGS) has been seen in recent years driving the Clinical Oncology Next Generation Sequencing Market Industry. The emergence of next-generation sequencing clinical applications in precision oncology has accelerated key company’s efforts to create new platforms that can be used for genomic assays. In February 2021, for instance, Congenica partnered with Gabriel Precision Oncology Ltd. to create an automatic software interface for clinical oncology interpretation using biotechnology. In routine clinical practice, this product will promote NGS-based molecular diagnostics of tumours. 

Report Coverage

The report: “Clinical Oncology Next Generation Sequencing Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Clinical Oncology Next Generation Sequencing Market.

By Technology Type: Whole Genome Sequencing, Whole Exome Sequencing and Targeted Sequencing & Resequencing Centrifuges.

By Application: Screening - Sporadic Cancer and Inherited Cancer, Companion Diagnostics and Other Diagnostics.

By Workflow: NGS Pre-Sequencing, NGS Sequencing and NGS Data Analysis.

By End Use: Hospitals/Clinics, Laboratories and Research Labs.

By Geography: North America (U.S, Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America) and RoW (Middle East and Africa).

Request Sample

Key Takeaways

The increasing need for successful treatment of various cancer types and scientific developments in immunology, molecular biology and genetics are likely to contribute to the growth of the Clinical Oncology Next Generation Sequencing industry.

Geographically, North America Clinical Oncology Next Generation Sequencing Market held the largest revenue share of 36% in 2020 owing to an increased emphasis on cancer treatment by government agencies, a rise in healthcare spending and the presence of sufficient resources in the healthcare industry in this region.

The growth of the market is driven by rising research and development activities using NGS technologies, growing NGS applications in clinical diagnosis and discovery applications that demand NGS technology.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market is provided in the Clinical Oncology Next Generation Sequencing Market.

Clinical Oncology Next Generation Sequencing Market Segment Analysis - By Technology Type

Based on Technology Type, Clinical Oncology Next Generation Sequencing Market is segmented into Whole Genome Sequencing, Whole Exome Sequencing and Targeted Sequencing & Resequencing Centrifuges. Targeted Sequencing & Resequencing Centrifuges accounted for the largest revenue market share in 2020 help reduce the expense, time, and volume of data analysed during tumour sample sequencing which is anticipated to favourably impact the segment growth. Targeted sequencing uses deep sequencing within an area of interest to identify recognized and novel variants. Illumina's 523-gene panel contains all the probable genes that have the ability to cause malignant tumours to develop. Medical laboratories have introduced the product to diagnose patients suffering from acute myeloid leukaemia. In addition, the efficacy of targeted panels for the identification of malignant tumors improves their clinical usefulness. In 64% of cancer cases, NGS panels are clinically beneficial, according to a report reported in JCO Precision Oncology, 2020 driving the Clinical Oncology Next Generation Sequencing Industry. Whole Genome Sequencing segment is anticipated to grow with the fastest CAGR of 8.3% in the forecast period 2021-2026 owing to the usefulness of this technology to discern and compare normal tissues from tumour tissues, segment growth. Moreover, whole-genome sequencing of cancer patients helps to identify therapies for existing mutations and also helps to target mutations ahead of time. It also helps analyse the prognosis of cancer and establish a treatment regimen depending on the genes affected aiding to the Clinical Oncology Next Generation Sequencing Market growth.

Inquiry Before Buying

Clinical Oncology Next Generation Sequencing Market Segment Analysis - By Application

Based on Application, Clinical Oncology Next Generation Sequencing Market is segmented into Screening - Sporadic Cancer and Inherited Cancer, Companion Diagnostics and Other Diagnostics. Screening accounted for the largest revenue market share in 2020. The most effective way to identify genetic alterations that can be targeted for clinical benefit in cancer patients is currently considered to be NGS-based testing. This technology enables clinicians to analyse several alterations of genes simultaneously. Moreover, as opposed to other pathology methods, technology needs less tumor tissues. An increase in the number of cancer sequencing projects is also increasing the growth of the segment. For instance, 38 different types of cancer were analysed by the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium by sequencing more than 2,600 tumour samples aiding to the market's growth. Companion Diagnostics segment is anticipated to grow with the fastest CAGR of 9.1% during the forecast period 2021-2026. Efforts taken by key market participants to develop advanced computational tools propel the segment growth. For instance, in January 2021, scientists from the MD Anderson Cancer Center created CopyKAT, a new computational tool to distinguish between normal as well as cancer cells in a tumour thus enhancing the Companion Diagnostics segment demand.

Clinical Oncology Next Generation Sequencing Market Segment Analysis - By Geography

Based on Geography, North America Clinical Oncology Next Generation Sequencing Market accounted for the 36% revenue share in 2020. This rise is accounted for by substantial efforts made by regulatory bodies to boost cancer screening detection in the U.S. For instance, the U.S.-initiated Cancer Genome Atlas programme, Next-generation sequencing has been conducted by the National Cancer Institute (NCI) of more than 20,000 primary cancer samples from 33 different cancer types. A consortium of 12 cancer centres, including Johns Hopkins University, Dana-Farber Cancer Institute, and others throughout the United States, is the NCI's Cancer Aim Discovery and Growth Network enhancing the Clinical Oncology Next Generation Sequencing Market. In January 2020, in the United States, the Intelligence Advanced Research Projects Activity provided $23 million to the Broad Institute and Harvard University, and DNA Script. In addition, the emergence of a range of laboratories, academic institutions and hospitals that provide early cancer detection and treatment services based on NGS is owing to the growth of the regional sector. For instance, EasyDNA Canada, a Toronto-based DNA Biotechnology testing company, provides Cancer Predisposition Panel tests that use NGS technology to recognise mutations in a total of 98 genes associated with 25 inherited cancers. The test helps to recognise people who at a later stage of their lives are at a high risk of developing cancer drive the regional growth. Asia-Pacific is predicted to be the fastest-growing region during the forecast period 2021- 2026 owing to the increasing automation in the pre-sequencing protocols in this particular region thereby aiding to regional growth.

Schedule a Call

Clinical Oncology Next Generation Sequencing Market Drivers

Increasing Prevalence of Cancer:

Cancer is the second leading cause of death worldwide, according to the WHO, and was responsible for an estimated 9.6 million fatalities in 2018. Need for cancer therapies is rising with the increasing number of cancer cases and deaths caused by cancer. Thus government of various economies focus on drug development, targeted sequencing for the reduction of cancer cases have also increased. Rising biomedical research using next-generation clinical oncology sequencing is estimated to create a favourable environment in the near future for the growth of the next-generation clinical oncology sequencing industry. With substantial advances in genetic sequencing and biomedical science, much research into monoclonal antibodies is now focused on discovering new development targets and optimizing their effectiveness for clinical practice, demonstrating a significant effect on the need for the Clinical Oncology Next Generation Sequencing Market.

Decreasing Sequencing Costs Are Highly Likely To Lead To Market Growth:

In clinical oncology, research and academic institutions are generally interested in the characteristic features of next-generation targeted sequencing technology. The next-generation sequencing techniques in clinical oncology give a high percentage of reads and cost-effectiveness per read. The arrival of low-cost sequencing platforms on the market has made this possible. This increases the overall growth of the next-generation sequencing market for clinical oncology. Several industry players, such as Roche and Illumina, have launched sequencing techniques that have reduced the cost of next-generation sequencing for clinical oncology. Government support for life science research is also estimated to result in the availability of funding for the undertaking of different next-generation sequencing projects in clinical oncology, as well as for the jobs of the staff needed which further act as a driving factor for the growth of the Clinical Oncology Industry.

Clinical Oncology Next Generation Sequencing Market Challenges

Major Regulatory Concerns & Lack Skilled Professionals:

Regulatory concerns regarding usage of Clinical Oncology Next Generation Sequencing Analysis and growing stringent government policy and regulation towards the quantity of service being used in application is restraining growth of the market. Market restrain is also owing to the difficulty in the management of large data and complications, associated with Big Data management. In addition, some of the ethical issues associated with whole-genome sequencing, coupled with the lack of awareness among people are constraining the growth of the market. In addition, the lack of skilled professionals with the sequencing that could be serious for diagnosis purpose set to restrain the market growth. It gets difficult when in an emergency situation, the queue of patients have to wait for experts in the required field negatively impacting the growth.

Buy Now

Clinical Oncology Next Generation Sequencing Industry Outlook:

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Clinical Oncology Next Generation Sequencing Market. Clinical Oncology Next Generation Sequencing Market top 10 companies are Illumina, Inc., Qiagen N.V., Pacific Biosciences of California, Inc., Takara Bio, Inc., Creative Biolabs, Mogene LC, F. Hoffmann-La Roche Ltd, Oxford Nanopore Technologies, Agilent Technologies and Thermo Fisher Scientific Inc.

Acquisitions/Product Launches:

In January 2021, 4baseCare, a start-up in precision oncology, partnered with the Advanced Centre for Cancer Treatment, Study and Education (ACTREC), India, to develop ClinOme, an AI-driven platform for clinical interpretation

In May 2020, Illumina, Inc., has partnered with Burning Rock Biotech Limited, a cancer test provider based in China, to promote the standardisation and development within China of the selection of NGS-based cancer therapy. The company has also signed an agreement to develop and commercialise myChoice tumour testing in China with Myriad Genetics, Inc.

In March 2019, Oxford Nanopore Technologies launched a new paradigm of smaller, on-demand DNA or RNA sequencing tests with the potential to transform a variety of applications where rapid insights are needed at a low cost.